BackTable / Urology / Podcast / Episode #241

Penile Cancer Management: Insights & Case Studies

with Dr. Juanita Crook and Dr. Andrea Apolo

How do the experts balance organ preservation, oncologic control, and emerging therapies in both localized and metastatic cases of penile cancer? This episode of BackTable Tumor Board focuses on penile cancer diagnosis and treatment, featuring urologic oncologist Dr. Charles Peyton (UAB), radiation oncologist Dr. Juanita Crook (UBC), and medical oncologist Dr. Andrea Apolo (NCI).

This podcast is supported by:

Ferring Pharmaceuticals

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Penile Cancer Management: Insights & Case Studies with Dr. Juanita Crook and Dr. Andrea Apolo on the BackTable Urology Podcast

Ep 241 Penile Cancer Management: Insights & Case Studies with Dr. Juanita Crook and Dr. Andrea Apolo

00:00 / 01:04

BackTable, LLC (Producer). (2025, June 17). Ep. 241 – Penile Cancer Management: Insights & Case Studies [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Andrea Apolo

Dr. Andrea Apolo is a urologic oncologist with the National Cancer Institute in Bethesda, Maryland.

Dr. Juanita Crook

Dr. Juanita Crook is a radiation oncologist at the University of British Columbia in Vancouver, Canada.

Dr. Charles Peyton

Dr. Charles Peyton is a urologic oncologist at the University of Alabama in Birmingham, Alabama.

Synopsis

This session covers case studies ranging from localized to advanced penile cancer, diagnostic practices, imaging preferences (MRI vs. CT), and treatment options, including surgery, brachytherapy, chemoradiation, and neoadjuvant chemotherapy. The multidisciplinary team highlights the complexities of treating this rare cancer, underscores the importance of physical exams, and stresses the necessity of personalized treatment plans. They also delve into the challenges of managing metastatic stages, potential salvage therapies, and the importance of clinical trials in enhancing treatment efficacy. The doctors also emphasize the potential of immunotherapy and chemotherapy combinations for metastatic disease.

Timestamps

00:00 - Introduction
02:23 - Imaging Preferences
03:29 - Biopsy vs Immediate Surgery
06:04 - Lymph Node Dissection vs Radiation
13:48 - Brachytherapy Techniques and Case Study
23:21 - Challenges in Advanced Penile Cancer
27:03 - Chemotherapy and Chemoradiation
30:15 - InPACT Trial
37:12 - Salvage Therapies and Exploring New Treatment Frontiers
44:25 - Support and Awareness for Penile Cancer
51:29 - Final Thoughts

Resources

Society of Urologic Oncology
https://suonet.org/home.aspx

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

Non-Muscle Invasive Bladder Cancer: Role of Medical Oncology with Dr. Tyler Stewart on the BackTable Urology Podcast

Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill on the BackTable Urology Podcast

Guide to Patient-Centered Counseling in NMIBC Care with Dr. Sima Porten and Dr. Patrick Hensley on the BackTable Urology Podcast

Contemporary Diagnostics in NMIBC: Clinical Insights with Dr. Anne Schuckman and Dr. Piyush Agarwal on the BackTable Urology Podcast

Renal Cancer Management: Tumor Board Discussion & Treatments with Dr. Raquib Hannan, Dr. Brandon Manley and Dr. Rana McKay on the BackTable Urology Podcast

Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast

Articles

Topics

Learn about Urologic Oncology on BackTable Urology

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.